April 22, 2015
MaxCyte and Johns Hopkins University Announce Strategic Immuno-Oncology Collaboration to Advance CAR T-cell Therapies | Business Wire
MaxCyte® Inc., the pioneer in cell therapies using scalable, high-performance cell transfection systems, today announces…